AGR2 and pancreatic neoplasm: To evaluate the therapeutic synergy between ferroptosis induction and AGR2 ablation, we conducted assessments of IKE—a metabolically stabilized derivative of the ferroptosis inducer erastin—in orthotopic pancreatic cancer models.